E2F8 and glioma: Knockdown of FGFR3‐AS1 inhibits OS cells proliferation and cell cycle progression in vitro and inhibits xenograft tumor growth of OS cells in vivo.1 In addition, HOXD‐AS1/miR‐130a sponge regulates glioma development by targeting E2F8.33